Espicom market intelligence, brought to you by Business Monitor InternationalOVERVIEW OF THE PHARMACEUTICAL MARKET IN TURKEYThe cooling economic environment and the weakening lira has moderated optimistic forecasts on the Turkish pharmaceutical market, especially as the government is the single largest reimburser of pharmaceuticals, covering 80-85% of total drug expenditure through various insurance and immunisation schemes. Price cutting and public discount decrees announced in November 2011 continue to affect the pharmaceutical market in 2012, as highlighted by the decrease in pharmaceutical spending in the first half of this year.Headline Expenditure Projections Pharmaceuticals: TRY17.21bn (US$10.24bn) in 2011 to TRY16.35bn (US$9.03bn) in 2012; -5.0% in local currency terms and -11.8% in US dollar terms. Local currency forecast downgraded from Q 4 12 on account of H112 data . Healthcare: TRY83.59bn (US$49.75bn) in 2011 to TRY92.02bn (US$50.84bn) in 2012; +10.1% in local currency terms and +2.2%in US dollar terms. Local currency forecast slightly increased from Q 4 12 due to increased healthcare investment . Medical devices: TRY4.33bn (US$2.58bn) in 2011 to TRY4.78bn (US$2.64bn) in 2012; +10.3% in local currency terms and +2.4% in US dollar terms. Local currency forecast broadly unchanged from Q 4 12. Competitive Landscape The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
The Pharmaceutical Market: Turkey, Business Monitor International
Published on January 2013
Report Summary
Espicom market intelligence, brought to you by Business Monitor International
OVERVIEW OF THE PHARMACEUTICAL MARKET IN TURKEY
The cooling economic environment and the weakening lira has moderated optimistic forecasts on the Turkish pharmaceutical market,
especially as the government is the single largest reimburser of pharmaceuticals, covering 80-85% of total drug expenditure through
various insurance and immunisation schemes. Price cutting and public discount decrees announced in November 2011 continue to
affect the pharmaceutical market in 2012, as highlighted by the decrease in pharmaceutical spending in the first half of this year.
Headline Expenditure Projections
Pharmaceuticals: TRY17.21bn (US$10.24bn) in 2011 to TRY16.35bn (US$9.03bn) in 2012; -5.0% in local currency terms and
-11.8% in US dollar terms. Local currency forecast downgraded from Q 4 12 on account of H112 data .
Healthcare: TRY83.59bn (US$49.75bn) in 2011 to TRY92.02bn (US$50.84bn) in 2012; +10.1% in local currency terms and +2.2%in
US dollar terms. Local currency forecast slightly increased from Q 4 12 due to increased healthcare investment .
Medical devices: TRY4.33bn (US$2.58bn) in 2011 to TRY4.78bn (US$2.64bn) in 2012; +10.3% in local currency terms and +2.4% in
US dollar terms. Local currency forecast broadly unchanged from Q 4 12.
Competitive Landscape
The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales -
for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
Table of Content
Table of Contents
Executive Summary 5
SWOT Analysis 7
Turkey Pharmaceuticals And Healthcare Industry SWOT 7
Turkey Political SWOT 8
Turkey Economic SWOT 8
Turkey Political SWOT 9
Pharmaceuticals & Healthcare Risk/Reward Ratings 10
Table: Central And Eastern Europe Pharmaceuticals & Healthcare Risk/Reward Ratings (RRRs), Q113 10
Rewards 11
The Pharmaceutical Market: Turkey, Business Monitor International (From Slideshare) Page 1/5

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Risks 11
Turkey ' Market Summary 13
Regulatory Regime 14
Intellectual Property Regime 15
Market Access Issues 16
Pricing Regime 17
Table: Turkish Pharmaceutical Pricing Decrees 18
Drug Price Inflation 19
Reimbursement Regime 20
Table: Pharmacist discount related to annual sales revenue (VAT excluded) 21
Industry Developments 22
Epidemiology 22
Non-Communicable Diseases 22
Healthcare Sector 23
Healthcare Insurance 24
Healthcare Infrastructure 25
Healthcare Financing 26
Research & Development 26
Clinical Trials Industry 27
Medical Devices Industry 28
Industry Forecast Scenario 31
Overall Market Forecast 31
Table: Turkey Pharmaceutical Sales, Historical Data And Forecasts 33
Healthcare Market Forecast 34
Table: Turkey Healthcare Expenditure Trends, Historical Data And Forecasts 35
Table: Turkey Government Healthcare Expenditure Trends, Historical Data And Forecasts 36
Table: Turkey Private Healthcare Expenditure Trends, Historical Data and Forecasts 36
Key Growth Factors ' Macroeconomic 37
Table: Turkey - Economic Activity 41
Prescription Drug Market Forecast 42
Table: Turkey Prescription Drug Market Indicators, Historical Data And Forecasts 43
Patented Drug Market Forecast 44
Generic Drug Market Forecast 45
Table: Turkey Generics Drug Market Indicators, Historical Data And Forecasts 46
OTC Medicine Market Forecast 47
Table: Turkey Over-The-Counter (OTC) Medicine Market Indicators, Historical Data and Forecasts 48
Pharmaceutical Trade Forecast 49
Table: Turkey Pharmaceutical Trade Data And Forecasts (US$mn) 49
Table: Turkey Pharmaceutical Trade Data And Forecasts (TRYmn) 50
Medical Device Market Forecast 51
Table: Turkey Medical Device Market Indicators, Historical Data And Forecasts 52
Other Healthcare Data 53
Key Risks To BMI's Forecasts 53
Competitive Landscape 54
Pharmaceutical Sector 54
Domestic Industry 55
Foreign Industry 55
Company Activity 56
The Pharmaceutical Market: Turkey, Business Monitor International (From Slideshare) Page 2/5

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Wholesale 57
Retail 58
Company Profiles 60
Local Companies 60
Abdi 'brahim 60
Eczaciba'i Pharmaceuticals 63
Sanovel Pharmaceuticals 66
Deva (EastPharma) 68
Mustafa Nevzat Ilac Sanayi (MN) Pharmaceuticals 71
Multinational Companies 74
Novartis 74
Pfizer 75
Sanofi 77
GlaxoSmithKline 79
Roche 81
AstraZeneca 83
Bayer 84
Merck & Co 86
Demographic Outlook 88
TURKEY - Population By Age Group 89
TURKEY - Population By Age Group 90
TURKEY - Key Population Ratios 91
TURKEY - Rural and Urban Population 91
Glossary 92
BMI Methodology 94
How We Generate Our Pharmaceutical Industry Forecasts 94
Risk/Reward Ratings Methodology 95
Ratings Overview 95
Table: Pharmaceutical Business Environment Indicators 96
Weighting 97
Table: Weighting Of Components 97
Sources 97
The Pharmaceutical Market: Turkey, Business Monitor International (From Slideshare) Page 3/5

4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
The Pharmaceutical Market: Turkey, Business Monitor International
Product Formats
Please select the product formats and the quantity you require.
1 User License--USD 1 397.25 Quantity: _____
Site License--USD 2 794.50 Quantity: _____
Corporate License--USD 8 383.50 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
The Pharmaceutical Market: Turkey, Business Monitor International (From Slideshare) Page 4/5

5. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
The Pharmaceutical Market: Turkey, Business Monitor International (From Slideshare) Page 5/5